This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria
Book Now
Menu
Book Now
Key Sessions
Giancarlo Francese, PhD
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
Gates Foundation
Gene Malin, PhD
AI for Rapid Response: How Digital Technologies can Accelerate Vaccine Development
CEPI
keyboard_arrow_right

Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 2 (29th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
BPI Europe 2026 Fun Run/Walk
Showing 1 of 1 Streams
07:00 - 08:00
BPI Europe 2026 Attendee Fun Run/Walk

Lace up your trainers for the BPI Europe 5k! It’s the fastest way to reach your target yield of morning energy. Fresh air, fast tracks, and the best networking in Vienna - brought to you by Novasign.

  • Meet: 7:00am
  • Start: 7:15am

All abilities welcome, staff will be there to chaperone attendees who are both running or walking.


To sign up for the Fun Run, please contact Kevin Cheng at kevin.cheng@informa.com

Showing 1 of 1 Streams
08:30 - 08:55
Registration & Morning Coffee
Showing 1 of 1 Streams
08:55 - 09:00KEYNOTE
Chairperson's Opening Remarks
  • Chris Spivey - Director of Industrial Relations and Strategic Partnerships, Informa Connect
09:00 - 09:30KEYNOTE
A Universal Blueprint for Affordability: Lessons in Formulation and Packaging for Global Health Equity
  • Giancarlo Francese, PhD - Senior Program Officer, Gates Foundation
09:30 - 10:00KEYNOTE
AI for Rapid Response: How Digital Technologies can Accelerate Vaccine Development
  • Gene Malin, PhD - CMC Lead, CEPI
Morning Break
Showing 2 of 2 Streams
10:00 - 10:45
Morning Networking Break in the Exhibit Hall
10:00 - 10:45
Innovation Showcase: Poster Viewing

Explore a showcase of scientific excellence. Discover the latest data and technical breakthroughs in our dedicated Poster Hall in the Exhibit Hall. Engage directly with the authors to discuss their findings, methodology, and results during this focused networking break.

Showing 5 of 5 Streams
10:45 - 10:50
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
10:50 - 11:20
Revisiting the Carbon Footprint of Single-Use Technologies in Biomanufacturing
  • Katharina Bruno-Thakur - Principal Scientist, F. Hoffmann-La Roche
11:20 - 11:50
Development Strategy for Rapid Implementation of Genome Engineered CHO Host Cell Lines into Existing Industrial Platform Processes
  • Preethi Krishnaraj - Post.Doc, Boehringer Ingelheim
11:50 - 12:20
Seeing More at Day-0: Enhancing Monoclonality Assurance in Cell Line Development
  • Adam Causer - Global Product Manager, Nova Biomedical
10:45 - 10:50
Chairperson's Opening Remarks
  • Matthias Müllner - CEO, bespark*bio
10:50 - 11:20
Glycosylation control and reduction of unwanted high-mannose glycans
  • Michael Butler - Principal Investigator, Cell Technology, NIBRT
11:20 - 11:50
Combining data driven and mechanistic models to assist in-silico media optimisation for fed-batch CHO cultures
  • Bhagya Yatipanthalawa - Research Fellow, The University of Melbourne / ARC Digital Bioprocess Development Hub
11:50 - 12:20
Scaling between lab and pilot scale bioreactors for fed-batch and perfusion experiments
  • Sebastian Eberle - Field Application Scientist, Thermo Fisher Scientific
  • Jan Ott - Lecturer, ZHAW Zürcher Hochschule für Angewandte Wissenschaften
10:45 - 10:50
Chairperson's Opening Remarks
  • Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University
10:50 - 11:20
Efficient host cell protein clearance: A study of membrane adsorbers and resins in biopharmaceutical processes
  • Ernest Šprager - Expert Science & Technology, DSPD, Novartis Technical Research & Development
11:20 - 11:50
Beyond Protein A: Building a Non-Affinity Purification Toolbox for the Post-mAb Era
  • Johannes Buyel - Head of Department, BOKU, Austria
11:50 - 12:20
Plot your path to higher productivity
  • Mark Schofield - Director, Science, Cytiva
10:45 - 10:50
Chairperson's Opening Remarks
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
10:50 - 11:20
[BioPhorum Case Study] Reconfiguring Biopharmaceutical Manufacturing: Evaluating the Multi-Modal Paradigm
  • Paul Cashen - Process Expert Commercialisation & Optimisation, BioPhorum (Sartorius)
11:20 - 11:50
Smart bioprocessing by hybrid R&D: enabling scalable CAR-T and stem cell manufacturing
  • Jan Schrooten - CEO, Antleron
11:50 - 12:20
Novel Large-Pore Cellulose Particles for Advanced Therapeutic Modalities: Efficient Viral Vector Purification
  • Chigusa Mori - Research Scientist, JNC Corporation
10:45 - 10:50
Chairperson's Opening Remarks
  • Weitao Jia, Ph.D. - Director, Pre-Pivotal Biologics Analytical Development and Product Characterization, Gilead Sciences
10:50 - 11:20
Beyond the Black Box: Utilising Physics-Informed AI to Build Trustworthy Digital Twins for Bioprocessing
  • Ignasi Bofarull-Manzano - : Industrial PhD Candidate, Senior CMC Data Scientist and Consultant, RWTH Aachen University
11:20 - 11:50
From In Silico Optimisation to Real-Time Process Control with Hybrid Modelling and PAT Integration
  • Moo Sun Hong - Assistant Professor, Seoul National University
11:50 - 12:20
Please Move to Another Track
Lunch, Networking & Exhibit Hall Activities
Showing 3 of 3 Streams
12:20 - 13:40
Lunch in the Exhibit Hall
12:30 - 13:30ROUNDTABLE
Digitalisation, Data and Interoperability Standards – How to Get the Best Out of Your Data
  • Patrick Courtney - Member Board of Directors, Standardization in Lab Automation (SiLA Standard)
12:30 - 12:40Live Labs
Live Lab: DataHow AG
12:40 - 12:50Live Labs
Live Lab: Brenntag
12:50 - 13:00Live Labs
Live Lab: Benchling
13:00 - 13:10Live Labs
Live Lab: Bruker
13:10 - 13:20Live Labs
Live Lab: Thermo Fisher Scientific
13:20 - 13:30Live Labs
Live Lab: Ecolab
Showing 5 of 5 Streams
13:40 - 13:45
Chairperson's Opening Remarks
  • Lekan Daramola - Consultant, LD BioConsulting Limited
13:45 - 14:15
Enabling Next-Generation ADC Manufacturing: Scaling Up Cell-Free Expression to Commercial GMP Scale
  • Daniel Fleischanderl - Head of Upstream Development, Development Operations Austria, Boehringer Ingelheim
14:15 - 14:45
Reimagining Biomanufacturing: Scalable Cell-Free Approaches for Vaccines and Therapeutics
  • Rochelle Aw - Assistant Professor in the School of Life Sciences, University of Nottingham
14:45 - 15:15
GMP Cell Banking: Strengthening Viral Safety and Regulatory Compliance with NGS
  • Florence Suavet - Chief Technical Officer, PathoQuest
13:40 - 13:45
Chairperson's Opening Remarks
  • Dieter Palmberger - CTO, bespark*bio
13:45 - 14:15
Key Strategies for Raw Material Readiness
  • Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
14:15 - 14:45
Scaling Up Intensification: Overcoming Clarification Bottlenecks at the Primary Recovery Stage
  • Patrick Harnedy - Senior Principal Engineer, Eli Lilly
14:45 - 15:15
High Sieving Performance Micro Filters for Intensified Cell Perfusion Processes: Challenges and opportunities of implementing continuous bioprocessing with perfusion mode.
  • Konstantin Agolli - Senior Product Manager & BioOptimal TFF Specialist, Asahi Kasei Bioprocess Europe
13:40 - 13:45
Chairperson's Opening Remarks
  • Alois Jungbauer - Professor, Dept. of Biotechnology, BOKU University
13:45 - 14:15
Magnetic Beads for Cell Separation and Purification: A Scalable, Column-Free Approach
  • Sebastian Schwaminger - Associate Professor, Medical University of Graz
14:15 - 14:45
Achieve Manufacturing Efficiencies Without Compromise

CDMOs and pharmaceutical companies face ongoing challenges of maximizing downstream processing efficiency, reducing operational costs, and expanding global operations without sacrificing product quality. Achieving these goals demands the careful selection of purification technologies that can withstand higher concentrations of caustic cleaning-in-place (CIP) solution, minimize ligand leakage, and optimize processes to prevent aggregation . These solutions must also offer extended life cycles, ensuring continued performance and productivity.

  • Ian Kerr - Field Application Specialist, Ecolab Life Sciences
14:45 - 15:15
Reduce bottlenecks and gain efficiency through innovation in buffer preparation and management
  • Shannon J. Ryan, Ph.D - Senior Director, Application Services, Avantor
13:40 - 13:45
Chairperson's Opening Remarks
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
13:45 - 14:15
From Open Bench to Closed System: Cell Therapy Manufacturing
  • Subash Ramamoorthy - Principal Automation & Robotics, Bayer AG
14:15 - 14:45
Industrializing 'Off-the-Shelf' Therapies: Scaling Stem Cell-Derived Cell Therapy Manufacturing
  • Volker Huppert - Chief Development Officer, Glycostem Therapeutics
14:45 - 15:15
To 1000L and beyond: Innovating AAV manufacturing for the next wave of gene therapies
  • Antoine Heron, PhD - Modality Consultant - Viral Vectors, MERCK
13:40 - 13:45
Chairperson's Opening Remarks
  • Weitao Jia, Ph.D. - Director, Pre-Pivotal Biologics Analytical Development and Product Characterization, Gilead Sciences
13:45 - 14:15
The Future of Self-Driving Laboratories as Innovative Entities to Revolutionise Bioprocess Development
  • Peter Neubauer - Chair for Bioprocess Engineering, Berlin University of Technology (TU Berlin), Germany
14:15 - 14:45
A First-Principles based Framework for Risk Reduction in scale-up and transfer of Bioprocesses
  • Christian Witz - CEO, SimVantage GmbH
14:45 - 15:15
Scientific Spotlight: ArgusEye
Afternoon Break
Showing 1 of 1 Streams
15:15 - 16:00
Afternoon Break in the Exhibit Hall
Showing 5 of 5 Streams
16:00 - 16:30
The Search for the AAV Holy Grail: Joining Product Demand and Technology Evolution
  • Kyle Zingaro - Head of Gene Therapy Process Sciences, UCB
16:30 - 17:00
Benchmarking HEK293 lineages: Impact on rAAV productivity and vector quality
  • Nikolaus Virgolini - Postdoctoral Researcher, BOKU University
16:00 - 16:30
The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
PANEL DISCUSSION: Collaboration - The Future Role Model for Resilient Biologics Supplies
  • Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
  • Ulrich Rümenapp - Senior Biotech Program Lead, Bayer AG
  • Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
  • Christian Eckermann - Corp. SVP BioPharma Network, Boehringer Ingelheim International GmbH
16:00 - 16:30
[Plenary hosted in Cell Culture & Upstream Processing] The Clarification Bottleneck: Novel Filtration and Centrifugation Strategies for High-Density Cell Cultures
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
16:30 - 17:00
[Plenary hosted in Cell Culture & Upstream Processing] PANEL DISCUSSION: Collaboration - The Future Role Model for Resilient Biologics Supplies
  • Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
  • Ulrich Rümenapp - Senior Biotech Program Lead, Bayer AG
  • Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
  • Christian Eckermann - Corp. SVP BioPharma Network, Boehringer Ingelheim International GmbH
16:00 - 16:30
An Automated Controlled Bioreactor Platform for Scalable 3D Expansion of induced Pluripotent Stem Cells
  • Andy Wiranata Wijaya - Bioprocess Development Lead, Nestlé Product Technology Center
16:30 - 17:00
PANEL DISCUSSION: The Platform Wars - The Future of Autologous, Allogeneic, and In Vivo Modalities

  • Can automation and process improvements make personalized autologous platforms commercially competitive against allogeneic alternatives?

  • What are the primary scientific and clinical hurdles for allogeneic therapies, including immune rejection, persistence, and long-term safety?

  • What is the realistic timeline for in vivo therapies to become mainstream, and could they make ex vivo approaches obsolete?

  • What does the future hold for these modalities in the next 5-10 years?

  • Dan Stanton - Industry Editor, Sartorius
  • Liedewij Vandewal - Senior Consultant – NextGen Therapies Supply & Manufacturing, Deloitte
  • Manuel Carrondo - Vice President, Instituto de Biologia Experimental e Tecnológica (iBET), Portugal
  • Claire Wartel - Director of Regulatory Affairs, Sartorius Polyplus
16:00 - 16:30
PANEL DISCUSSION: Closing the Digital Skills Gap
  • Steven Fuller - Founder & Director, Race in STEM
  • Jason Beckwith, PhD DBA MBA - SVP Talent Science & Thought Leadership, BioTalent
  • Alessandro Cataldo, PhD - Process Development Scientist, Takeda
  • Sophie Madden - Manager, Life Sciences and Healthcare, Sia/LBG
16:30 - 17:00
AI Adoption in Biomanufacturing
  • Eva Aning - Co-Founder & CEO, Quintess Quality AI
Networking Party
Showing 1 of 1 Streams
17:00 - 19:00
BPI Europe 2026 Off-Site Networking Party

After a day of deep-dives, it’s time to kick back in true Austrian style. Join us at Prater Alm, a rustic Alpine gem nestled right in the heart of Vienna’s iconic Prater funfair!

Just a short, scenic walk from VIECON, we’re bringing the mountains to the city for a night of high-impact networking.

Expect authentic Austrian delicacies, and plenty of local drinks to keep the conversation flowing. It’s the perfect backdrop to forge new partnerships outside the conference walls.

Main Conference Day 1 (28th April 2026)
NextMain Conference Day 3 (30th April 2026)
Filter
Streams
Choose Day